Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FSTL1,Follistatin-related protein 1,Inverse variance weighted,5,0.78 [0.65-0.94],0.0101033636852319,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,0.85 [0.75-0.97],0.0160327627277784,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SCGN,Secretagogin,Inverse variance weighted,5,0.85 [0.74-0.97],0.0188789867547052,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,5,0.86 [0.77-0.98],0.0190496468859387,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SEL1L,Protein sel-1 homolog 1,Inverse variance weighted,5,0.85 [0.75-0.98],0.019924222641093,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SPP1,Osteopontin,Inverse variance weighted,5,0.86 [0.76-0.98],0.0251542311137778,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,5,0.87 [0.77-0.98],0.0260412640416333,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,5,0.88 [0.78-0.99],0.0351578315434327,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,5,0.87 [0.77-0.99],0.0356647635257453,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,5,0.88 [0.78-1],0.0427297463802673,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PALM,Paralemmin-1,Inverse variance weighted,5,0.88 [0.77-1],0.04567185169012,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CLEC3B,Tetranectin,Inverse variance weighted,5,0.86 [0.74-1],0.0481149799988565,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CFD,Complement factor D,Inverse variance weighted,5,0.88 [0.77-1],0.0491189703411622,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PRG2,Bone marrow proteoglycan,Inverse variance weighted,5,0.88 [0.77-1],0.0566025823720108,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1.13 [1-1.29],0.058549414390247,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NEFL,Neurofilament light polypeptide,Inverse variance weighted,5,0.89 [0.8-1.01],0.0624079123202959,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,5,0.89 [0.79-1.01],0.0637329030047244,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FAP,Prolyl endopeptidase FAP,Inverse variance weighted,5,0.89 [0.78-1.01],0.0661775101325857,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,5,1.12 [0.99-1.27],0.0703945500395536,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RSPO3,R-spondin-3,Inverse variance weighted,5,0.89 [0.79-1.01],0.0710298684951164,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,5,1.11 [0.99-1.25],0.0712435157783265,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,5,0.9 [0.79-1.01],0.0719134929628698,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TFF2,Trefoil factor 2,Inverse variance weighted,5,1.12 [0.99-1.28],0.0732317871955967,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CNTN5,Contactin-5,Inverse variance weighted,5,0.85 [0.7-1.02],0.077872201141148,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SNCG,Gamma-synuclein,Inverse variance weighted,5,0.91 [0.82-1.01],0.0787864098779079,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FBLN2,Fibulin-2,Inverse variance weighted,5,0.89 [0.78-1.02],0.0822589247593504,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,5,0.9 [0.79-1.01],0.0830289719166321,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,5,0.89 [0.78-1.02],0.0838043095527027,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,5,0.9 [0.79-1.02],0.0881115759452044,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Inverse variance weighted,5,1.12 [0.98-1.28],0.0896404738401386,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SEPTIN8,Septin-8,Inverse variance weighted,5,0.88 [0.75-1.02],0.0938256299176855,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,5,0.89 [0.78-1.02],0.0962235194074519,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GDF15,Growth/differentiation factor 15,Inverse variance weighted,5,1.1 [0.98-1.22],0.0967706188847881,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,EDN1,Endothelin-1,Inverse variance weighted,5,0.89 [0.78-1.02],0.0972829596149104,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RNASE10,Inactive ribonuclease-like protein 10,Inverse variance weighted,5,0.91 [0.82-1.02],0.0978723903814554,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RTN4R,Reticulon-4 receptor,Inverse variance weighted,5,0.9 [0.79-1.02],0.100536596824586,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,5,0.91 [0.81-1.02],0.10347253764063,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CLMP,CXADR-like membrane protein,Inverse variance weighted,5,0.91 [0.8-1.02],0.10369983866442,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,5,1.18 [0.96-1.45],0.108989863307533,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,5,0.91 [0.81-1.02],0.110186884606142,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,KLRD1,Natural killer cells antigen CD94,Inverse variance weighted,5,1.1 [0.98-1.25],0.111863776483315,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SCG2,Secretogranin-2,Inverse variance weighted,5,0.88 [0.75-1.03],0.112247994419299,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,5,0.9 [0.78-1.03],0.118324072315975,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MB,Myoglobin,Inverse variance weighted,5,0.91 [0.81-1.03],0.126570849289856,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ACTA2,"Actin, aortic smooth muscle",Inverse variance weighted,5,0.87 [0.73-1.04],0.126941539922575,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,5,1.1 [0.97-1.25],0.12774454683352,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,5,1.1 [0.97-1.25],0.129826086022144,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,5,0.9 [0.79-1.03],0.131286423244946,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,Inverse variance weighted,5,0.87 [0.72-1.04],0.131361567897056,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD300C,CMRF35-like molecule 6,Inverse variance weighted,5,0.91 [0.81-1.03],0.140096286404495,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,BCAM,Basal cell adhesion molecule,Inverse variance weighted,5,0.86 [0.7-1.05],0.140591381954465,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GOLM2,Protein GOLM2,Inverse variance weighted,5,0.91 [0.79-1.03],0.141096142893708,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PGF,Placenta growth factor,Inverse variance weighted,5,0.92 [0.81-1.03],0.143674337950259,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,5,0.86 [0.69-1.05],0.144543376507572,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,KLK11,Kallikrein-11,Inverse variance weighted,5,0.91 [0.8-1.04],0.153156249294455,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCL21,C-C motif chemokine 21,Inverse variance weighted,5,1.1 [0.96-1.25],0.153736012495208,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PTN,Pleiotrophin,Inverse variance weighted,5,0.91 [0.8-1.04],0.154245628656495,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CSF3R,Granulocyte colony-stimulating factor receptor,Inverse variance weighted,5,0.91 [0.79-1.04],0.154341246900788,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,5,0.9 [0.79-1.04],0.154734658710532,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,DSG2,Desmoglein-2,Inverse variance weighted,5,0.86 [0.7-1.06],0.155751629344716,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,5,0.91 [0.81-1.04],0.156280352868543,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CA12,Carbonic anhydrase 12,Inverse variance weighted,5,0.91 [0.8-1.04],0.156322744174178,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CRH,Corticoliberin,Inverse variance weighted,5,1.12 [0.96-1.3],0.157654291570623,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,5,1.08 [0.97-1.21],0.160131643477617,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,5,1.1 [0.96-1.25],0.164071647846874,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,5,0.91 [0.8-1.04],0.164283400345493,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MEP1B,Meprin A subunit beta,Inverse variance weighted,5,1.11 [0.96-1.28],0.166231547508338,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD160,CD160 antigen,Inverse variance weighted,5,1.09 [0.96-1.24],0.169185068283116,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,5,1.09 [0.96-1.23],0.171375373562613,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,5,0.92 [0.82-1.04],0.172253305936024,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,5,1.09 [0.96-1.25],0.172343753593166,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ANXA10,Annexin A10,Inverse variance weighted,5,1.1 [0.96-1.26],0.172356598980616,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,5,0.91 [0.8-1.04],0.175005399311272,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MMP12,Macrophage metalloelastase,Inverse variance weighted,5,1.11 [0.96-1.28],0.175158836747861,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,5,0.92 [0.81-1.04],0.176864176298006,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,0.91 [0.8-1.04],0.17865843859355,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,KLK4,Kallikrein-4,Inverse variance weighted,5,1.09 [0.96-1.25],0.179519933164242,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,5,1.12 [0.95-1.32],0.181947286635372,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,5,0.92 [0.82-1.04],0.182001204173182,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,5,1.1 [0.96-1.25],0.183242743299186,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,5,0.92 [0.81-1.04],0.183378338754796,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MYL3,Myosin light chain 3,Inverse variance weighted,5,0.91 [0.78-1.05],0.188582416877391,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,POF1B,Protein POF1B,Inverse variance weighted,5,0.91 [0.8-1.05],0.189402342667167,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PENK,Proenkephalin-A,Inverse variance weighted,5,0.91 [0.79-1.05],0.189587432843722,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,5,0.9 [0.77-1.05],0.189785913751805,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,AGRN,Agrin,Inverse variance weighted,5,1.1 [0.95-1.28],0.190893475515721,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HJV,Hemojuvelin,Inverse variance weighted,5,1.1 [0.95-1.27],0.191300301256326,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,5,0.92 [0.8-1.05],0.191716511902935,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,5,0.92 [0.82-1.04],0.192495380118479,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ADM,Pro-adrenomedullin,Inverse variance weighted,5,1.09 [0.96-1.23],0.194791937811791,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,OGN,Mimecan,Inverse variance weighted,5,0.93 [0.83-1.04],0.195491112262534,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,5,1.12 [0.94-1.34],0.196376915315332,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNC,Tenascin,Inverse variance weighted,5,1.12 [0.94-1.33],0.197141978517222,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,COLEC12,Collectin-12,Inverse variance weighted,5,0.92 [0.81-1.05],0.200393824981222,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,5,1.08 [0.96-1.22],0.201774223853514,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MILR1,Allergin-1,Inverse variance weighted,5,1.1 [0.95-1.27],0.20198012644134,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TSPAN1,Tetraspanin-1,Inverse variance weighted,5,0.92 [0.81-1.04],0.203832561900449,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CTSS,Cathepsin S,Inverse variance weighted,5,1.09 [0.95-1.26],0.210345837351202,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GSN,Gelsolin,Inverse variance weighted,5,0.86 [0.68-1.09],0.219369989836405,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,5,0.92 [0.81-1.05],0.220857036327338,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PTX3,Pentraxin-related protein PTX3,Inverse variance weighted,5,1.09 [0.95-1.24],0.225699417443392,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,5,0.93 [0.83-1.04],0.230084001445537,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,APOA1,Apolipoprotein A-I,Inverse variance weighted,5,1.08 [0.95-1.22],0.232733200614237,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,5,0.92 [0.81-1.05],0.232767763515797,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,5,0.89 [0.73-1.08],0.233305136717767,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,5,0.92 [0.81-1.05],0.233803288844185,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,DPT,Dermatopontin,Inverse variance weighted,5,0.93 [0.83-1.05],0.235255909530428,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,5,1.09 [0.94-1.27],0.237790504093903,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,5,0.92 [0.81-1.05],0.240170028964702,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,DPP4,Dipeptidyl peptidase 4,Inverse variance weighted,5,1.09 [0.94-1.27],0.241755349593475,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,5,0.93 [0.82-1.05],0.241861436065088,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,5,0.93 [0.81-1.05],0.244754573471983,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,1.09 [0.94-1.26],0.251502182355212,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MYBPC1,"Myosin-binding protein C, slow-type",Inverse variance weighted,5,0.91 [0.78-1.07],0.255231305865149,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,5,0.93 [0.82-1.06],0.256903194736421,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,5,1.09 [0.94-1.25],0.258836596157601,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,5,0.87 [0.69-1.11],0.270373140292947,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,5,0.93 [0.81-1.06],0.274787443070673,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SUSD4,Sushi domain-containing protein 4,Inverse variance weighted,5,0.93 [0.82-1.06],0.275478686193977,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LY96,Lymphocyte antigen 96,Inverse variance weighted,5,1.08 [0.94-1.23],0.276108180670478,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,5,1.07 [0.94-1.23],0.283739724957586,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL17C,Interleukin-17C,Inverse variance weighted,5,0.93 [0.81-1.06],0.284143400903271,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,5,1.06 [0.95-1.18],0.285524412296702,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,1.07 [0.94-1.22],0.286503668179668,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LMNB2,Lamin-B2,Inverse variance weighted,5,0.93 [0.82-1.06],0.28771880417877,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,5,0.93 [0.82-1.06],0.28851828109583,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ANG,Angiogenin,Inverse variance weighted,5,1.1 [0.92-1.31],0.291347607024727,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,5,0.93 [0.81-1.07],0.293377214107017,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,5,0.93 [0.82-1.06],0.294265677074788,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",Inverse variance weighted,5,1.07 [0.94-1.22],0.297726743556749,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,0.92 [0.79-1.08],0.299739880589355,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,5,1.07 [0.94-1.22],0.301789268683979,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HIP1R,Huntingtin-interacting protein 1-related protein,Inverse variance weighted,5,0.92 [0.79-1.08],0.30296467825551,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,5,0.91 [0.77-1.09],0.303965286940861,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SCN4B,Sodium channel subunit beta-4,Inverse variance weighted,5,0.94 [0.84-1.06],0.304643133307873,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,DRAXIN,Draxin,Inverse variance weighted,5,0.94 [0.83-1.06],0.305084669128393,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,STC2,Stanniocalcin-2,Inverse variance weighted,5,1.07 [0.94-1.23],0.305599556610007,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CALB1,Calbindin,Inverse variance weighted,5,0.91 [0.77-1.09],0.308956011718423,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD276,CD276 antigen,Inverse variance weighted,5,0.95 [0.85-1.06],0.316221205460176,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ZBTB17,Zinc finger and BTB domain-containing protein 17,Inverse variance weighted,5,1.07 [0.94-1.22],0.317184184015572,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,5,0.93 [0.82-1.07],0.320582196679132,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,5,0.94 [0.83-1.06],0.322845235305116,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,DTNB,Dystrobrevin beta,Inverse variance weighted,5,0.94 [0.83-1.07],0.323379127329105,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TFRC,Transferrin receptor protein 1,Inverse variance weighted,5,1.07 [0.93-1.23],0.328126996395145,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,5,0.93 [0.8-1.08],0.329864981331606,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,5,0.91 [0.76-1.1],0.330640129809213,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,0.94 [0.82-1.07],0.330763971874736,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FAM3B,Protein FAM3B,Inverse variance weighted,5,0.94 [0.83-1.06],0.332566959459562,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,5,0.95 [0.85-1.06],0.332865710509644,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PRSS8,Prostasin,Inverse variance weighted,5,1.1 [0.91-1.32],0.333954110485468,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,Inverse variance weighted,5,1.06 [0.94-1.21],0.33442624441989,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,AREG,Amphiregulin,Inverse variance weighted,5,1.07 [0.93-1.22],0.335142732097215,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD83,CD83 antigen,Inverse variance weighted,5,1.11 [0.9-1.36],0.335453088554885,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CST3,Cystatin-C,Inverse variance weighted,5,1.06 [0.94-1.2],0.339998407325894,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,5,0.92 [0.77-1.1],0.348953440249611,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,5,0.94 [0.83-1.07],0.350689786455186,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TFF3,Trefoil factor 3,Inverse variance weighted,5,0.94 [0.83-1.07],0.352141847612372,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,VWC2,Brorin,Inverse variance weighted,5,0.94 [0.83-1.07],0.352783383533113,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,5,1.06 [0.93-1.21],0.353827182302303,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,5,1.06 [0.93-1.21],0.357555383020216,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,REG1B,Lithostathine-1-beta,Inverse variance weighted,5,0.94 [0.82-1.08],0.358178211419981,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CXCL13,C-X-C motif chemokine 13,Inverse variance weighted,5,1.06 [0.93-1.22],0.358688373386047,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ANGPT2,Angiopoietin-2,Inverse variance weighted,5,0.91 [0.74-1.12],0.359978984687728,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,5,0.94 [0.83-1.07],0.360452028588788,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,5,0.94 [0.82-1.07],0.36270340456517,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD300E,CMRF35-like molecule 2,Inverse variance weighted,5,0.94 [0.84-1.07],0.364082303698727,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NRP1,Neuropilin-1,Inverse variance weighted,5,0.93 [0.78-1.09],0.366187727890131,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,5,0.93 [0.79-1.09],0.367395131230638,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,5,0.94 [0.83-1.07],0.371471544031067,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,5,1.09 [0.9-1.33],0.37154538553106,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,DDR1,Epithelial discoidin domain-containing receptor 1,Inverse variance weighted,5,0.94 [0.83-1.07],0.371709553490432,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,5,0.95 [0.84-1.07],0.371728003762009,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RNASE6,Ribonuclease K6,Inverse variance weighted,5,1.06 [0.94-1.19],0.374381472490943,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,OSM,Oncostatin-M,Inverse variance weighted,5,1.06 [0.93-1.21],0.376505051572756,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FOLR2,Folate receptor beta,Inverse variance weighted,5,0.92 [0.76-1.11],0.376731052734801,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,5,0.94 [0.83-1.07],0.376747255667697,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CAPG,Macrophage-capping protein,Inverse variance weighted,5,1.05 [0.95-1.16],0.379749337132471,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PROS1,Vitamin K-dependent protein S,Inverse variance weighted,5,1.06 [0.93-1.21],0.381230935650395,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD163,Scavenger receptor cysteine-rich type 1 protein M130,Inverse variance weighted,5,1.06 [0.93-1.2],0.381615035686638,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,5,1.06 [0.93-1.2],0.382080204360132,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CTSL,Cathepsin L1,Inverse variance weighted,5,1.06 [0.93-1.21],0.383846957451751,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,5,0.95 [0.83-1.07],0.38799620308556,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,0.94 [0.83-1.08],0.388086121245289,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,UMOD,Uromodulin,Inverse variance weighted,5,1.05 [0.94-1.16],0.388689439891166,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SERPINA1,Alpha-1-antitrypsin,Inverse variance weighted,5,1.08 [0.9-1.3],0.388892094552602,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,5,0.95 [0.83-1.07],0.388992989872614,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,1.05 [0.93-1.19],0.393023872697558,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,1.06 [0.93-1.2],0.393711008487091,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PRTN3,Myeloblastin,Inverse variance weighted,5,1.08 [0.9-1.29],0.395363456467507,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,5,0.95 [0.83-1.07],0.395417865093778,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,5,1.06 [0.93-1.2],0.396211969383319,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PEPD,Xaa-Pro dipeptidase,Inverse variance weighted,5,0.95 [0.83-1.07],0.398638811435343,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NECTIN4,Nectin-4,Inverse variance weighted,5,0.95 [0.83-1.08],0.399366378979333,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FSTL3,Follistatin-related protein 3,Inverse variance weighted,5,0.95 [0.83-1.08],0.401189498349681,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PDCD1,Programmed cell death protein 1,Inverse variance weighted,5,0.95 [0.83-1.08],0.40414648450557,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,STC1,Stanniocalcin-1,Inverse variance weighted,5,0.95 [0.83-1.08],0.4076019687363,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RGMB,RGM domain family member B,Inverse variance weighted,5,0.93 [0.79-1.1],0.409756714258388,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,VSTM1,V-set and transmembrane domain-containing protein 1,Inverse variance weighted,5,1.05 [0.94-1.16],0.409992664146448,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,5,1.05 [0.93-1.19],0.413037422885432,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NECTIN2,Nectin-2,Inverse variance weighted,5,1.06 [0.93-1.21],0.416329956351573,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HSPB6,Heat shock protein beta-6,Inverse variance weighted,5,0.95 [0.84-1.08],0.417678566463691,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SHISA5,Protein shisa-5,Inverse variance weighted,5,0.93 [0.79-1.1],0.419626135856839,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,5,0.95 [0.84-1.08],0.424008774966244,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HYAL1,Hyaluronidase-1,Inverse variance weighted,5,1.06 [0.92-1.2],0.427094043261876,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,5,1.05 [0.92-1.2],0.428226323180671,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,5,1.06 [0.91-1.24],0.428703606345776,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CALCA,Calcitonin,Inverse variance weighted,5,0.92 [0.75-1.13],0.43050212776495,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,Inverse variance weighted,5,0.92 [0.76-1.13],0.432063008982974,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,REN,Renin,Inverse variance weighted,5,1.05 [0.93-1.2],0.432798122953095,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,5,0.95 [0.83-1.08],0.434519063738646,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,5,0.95 [0.84-1.08],0.43622581549902,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CKB,Creatine kinase B-type,Inverse variance weighted,5,0.95 [0.83-1.08],0.438161721798277,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PCDH17,Protocadherin-17,Inverse variance weighted,5,0.93 [0.77-1.12],0.438890206341314,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,5,0.91 [0.72-1.15],0.439442698687429,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LAYN,Layilin,Inverse variance weighted,5,1.07 [0.9-1.27],0.441380170155041,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TFF1,Trefoil factor 1,Inverse variance weighted,5,1.05 [0.93-1.19],0.441923906578318,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MSLN,Mesothelin,Inverse variance weighted,5,1.05 [0.93-1.18],0.442523350626749,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCN4,CCN family member 4,Inverse variance weighted,5,0.95 [0.84-1.08],0.447063889975627,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,KLK10,Kallikrein-10,Inverse variance weighted,5,0.94 [0.8-1.1],0.448329444741607,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FAM3D,Protein FAM3D,Inverse variance weighted,5,0.96 [0.85-1.08],0.459378891853428,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,5,0.95 [0.83-1.09],0.459403735715896,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,5,1.06 [0.91-1.23],0.460024481943987,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,5,1.05 [0.92-1.2],0.462167210071009,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,5,0.95 [0.82-1.1],0.462355823723194,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,5,1.1 [0.86-1.4],0.465042785054098,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,BSG,Basigin,Inverse variance weighted,5,0.95 [0.84-1.09],0.468380852413598,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,5,0.9 [0.69-1.19],0.469135298203232,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL15,Interleukin-15,Inverse variance weighted,5,0.95 [0.83-1.09],0.470131004274218,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SPOCK1,Testican-1,Inverse variance weighted,5,0.95 [0.84-1.09],0.473502451824199,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,5,0.95 [0.84-1.09],0.47469887129798,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CTSO,Cathepsin O,Inverse variance weighted,5,0.95 [0.82-1.1],0.476800729478934,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD27,CD27 antigen,Inverse variance weighted,5,1.05 [0.92-1.19],0.478425983090633,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,DSC2,Desmocollin-2,Inverse variance weighted,5,0.95 [0.82-1.1],0.484474033617361,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,USP28,Ubiquitin carboxyl-terminal hydrolase 28,Inverse variance weighted,5,0.94 [0.8-1.12],0.486570918183726,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FGF21,Fibroblast growth factor 21,Inverse variance weighted,5,0.95 [0.84-1.09],0.487074702055056,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,5,1.05 [0.92-1.2],0.487630808316269,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LGALS3,Galectin-3,Inverse variance weighted,5,0.95 [0.84-1.09],0.487634907978467,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,5,1.05 [0.92-1.18],0.490578794752776,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,5,1.05 [0.92-1.2],0.490589995924587,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,5,0.94 [0.78-1.13],0.500646597302256,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,WNT9A,Protein Wnt-9a,Inverse variance weighted,5,0.95 [0.83-1.1],0.501929537039522,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Inverse variance weighted,5,1.05 [0.92-1.19],0.502089481781294,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL18,Interleukin-18,Inverse variance weighted,5,1.04 [0.92-1.19],0.504203703821539,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PALM2,Paralemmin-2,Inverse variance weighted,5,0.96 [0.84-1.09],0.506721765836101,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ADGRG2,Adhesion G-protein coupled receptor G2,Inverse variance weighted,5,0.95 [0.83-1.1],0.507634015363505,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MSMB,Beta-microseminoprotein,Inverse variance weighted,5,0.96 [0.86-1.08],0.508665921147247,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,5,1.05 [0.91-1.22],0.508829382258671,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LCN15,Lipocalin-15,Inverse variance weighted,5,0.96 [0.85-1.09],0.50927455177166,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,5,1.05 [0.91-1.21],0.510742680970271,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CTSZ,Cathepsin Z,Inverse variance weighted,5,0.96 [0.84-1.09],0.511152020923733,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,5,0.92 [0.7-1.19],0.515537259291674,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,C9,Complement component C9,Inverse variance weighted,5,0.95 [0.83-1.1],0.515788584493529,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,5,0.96 [0.84-1.09],0.515901570630254,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,5,0.95 [0.82-1.11],0.517697490030509,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FGF23,Fibroblast growth factor 23,Inverse variance weighted,5,0.96 [0.84-1.09],0.523074654372859,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CHRDL1,Chordin-like protein 1,Inverse variance weighted,5,0.94 [0.76-1.15],0.525722009165258,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,5,1.04 [0.92-1.18],0.526986677550143,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SRPX,Sushi repeat-containing protein SRPX,Inverse variance weighted,5,0.96 [0.85-1.09],0.529759377189355,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,INHBB,Inhibin beta B chain,Inverse variance weighted,5,0.96 [0.84-1.09],0.531405774177055,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,0.96 [0.85-1.09],0.532033313051336,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,5,1.07 [0.87-1.3],0.532088058018591,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,5,1.06 [0.88-1.29],0.532403681034441,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,APOM,Apolipoprotein M,Inverse variance weighted,5,1.04 [0.92-1.19],0.532743179366103,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MMP3,Stromelysin-1,Inverse variance weighted,5,0.97 [0.87-1.08],0.533475033352957,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Inverse variance weighted,5,0.96 [0.84-1.1],0.533592285263984,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,5,1.04 [0.92-1.18],0.534516558232805,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,5,1.05 [0.9-1.22],0.53555320811437,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,5,0.95 [0.81-1.12],0.540157732474986,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,B2M,Beta-2-microglobulin,Inverse variance weighted,5,1.04 [0.92-1.18],0.54282744692674,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,5,0.95 [0.81-1.12],0.546784163590488,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,5,0.96 [0.83-1.1],0.551600979961249,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GAST,Gastrin,Inverse variance weighted,5,0.96 [0.82-1.11],0.554748160000978,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,5,0.93 [0.73-1.19],0.560393599777048,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FETUB,Fetuin-B,Inverse variance weighted,5,1.05 [0.88-1.27],0.566650928391194,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,5,0.96 [0.85-1.1],0.568486993643705,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCL3,C-C motif chemokine 3,Inverse variance weighted,5,1.06 [0.88-1.27],0.568818026219023,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SDC1,Syndecan-1,Inverse variance weighted,5,1.04 [0.91-1.18],0.569000042826713,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ELN,Elastin,Inverse variance weighted,5,0.97 [0.88-1.07],0.56909058318969,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ULBP2,UL16-binding protein 2,Inverse variance weighted,5,0.95 [0.8-1.13],0.57138005699422,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SEMA3F,Semaphorin-3F,Inverse variance weighted,5,1.04 [0.91-1.18],0.571469505689927,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,Inverse variance weighted,5,1.04 [0.92-1.17],0.575016863472894,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,5,0.96 [0.84-1.1],0.576251692821504,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,Inverse variance weighted,5,0.96 [0.84-1.1],0.578381711004916,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,5,0.97 [0.86-1.09],0.578759220342364,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,5,1.03 [0.93-1.14],0.578873577395804,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD300A,CMRF35-like molecule 8,Inverse variance weighted,5,0.96 [0.84-1.11],0.581277296779081,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SLC39A14,Zinc transporter ZIP14,Inverse variance weighted,5,0.94 [0.74-1.18],0.581544076304669,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PZP,Pregnancy zone protein,Inverse variance weighted,5,0.95 [0.8-1.14],0.584199376736738,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,BTN2A1,Butyrophilin subfamily 2 member A1,Inverse variance weighted,5,0.95 [0.81-1.13],0.584907624285005,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,5,0.95 [0.8-1.14],0.585152250191465,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CDH2,Cadherin-2,Inverse variance weighted,5,0.95 [0.77-1.16],0.585407616476094,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,DPY30,Protein dpy-30 homolog,Inverse variance weighted,5,1.07 [0.84-1.35],0.591915985079385,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,5,1.04 [0.89-1.23],0.594763353811768,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,Inverse variance weighted,5,0.96 [0.83-1.11],0.595513329679917,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,1.04 [0.91-1.18],0.595523178832234,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,5,0.97 [0.86-1.09],0.596042438962382,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ITGAM,Integrin alpha-M,Inverse variance weighted,5,1.04 [0.9-1.2],0.596640366995626,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,C7,Complement component C7,Inverse variance weighted,5,0.97 [0.86-1.09],0.598581178674476,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCL16,C-C motif chemokine 16,Inverse variance weighted,5,1.03 [0.92-1.15],0.599868902230858,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL10,Interleukin-10,Inverse variance weighted,5,0.94 [0.76-1.17],0.60069308328458,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PSAP,Prosaposin,Inverse variance weighted,5,0.95 [0.78-1.15],0.602715977344496,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,5,0.95 [0.8-1.14],0.603331068879861,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFSF8,Tumor necrosis factor ligand superfamily member 8,Inverse variance weighted,5,1.04 [0.91-1.18],0.604645669255632,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,1.06 [0.86-1.29],0.605024186635347,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,5,1.04 [0.91-1.18],0.606399492557291,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SELENOP,Selenoprotein P,Inverse variance weighted,5,1.04 [0.91-1.18],0.606629345874135,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCN3,CCN family member 3,Inverse variance weighted,5,0.97 [0.86-1.09],0.607867117669541,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,5,0.97 [0.85-1.1],0.608479609422194,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,5,0.96 [0.83-1.12],0.612245500319565,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ADA2,Adenosine deaminase 2,Inverse variance weighted,5,1.03 [0.91-1.17],0.612640734901253,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,KLK8,Kallikrein-8,Inverse variance weighted,5,0.97 [0.86-1.1],0.614522599891578,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,5,0.95 [0.78-1.16],0.615142808143693,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FABP4,"Fatty acid-binding protein, adipocyte",Inverse variance weighted,5,0.97 [0.86-1.1],0.616648897860811,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PLXNB2,Plexin-B2,Inverse variance weighted,5,0.97 [0.87-1.09],0.61736593805358,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,5,1.03 [0.92-1.16],0.617786906923951,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,XG,Glycoprotein Xg,Inverse variance weighted,5,1.03 [0.93-1.13],0.618905647881707,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD93,Complement component C1q receptor,Inverse variance weighted,5,0.95 [0.78-1.16],0.619237310955421,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,5,0.96 [0.8-1.15],0.619879502663557,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SEMA7A,Semaphorin-7A,Inverse variance weighted,5,1.04 [0.89-1.21],0.625372013060716,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,AMBP,Protein AMBP,Inverse variance weighted,5,0.97 [0.85-1.1],0.626347292805593,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,5,0.97 [0.86-1.1],0.626838369109367,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GUCA2A,Guanylin,Inverse variance weighted,5,1.03 [0.91-1.18],0.627457153064127,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ITGAV,Integrin alpha-V,Inverse variance weighted,5,0.96 [0.81-1.14],0.632196069925267,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PON1,Serum paraoxonase/arylesterase 1,Inverse variance weighted,5,1.05 [0.86-1.28],0.635624606255813,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,5,0.97 [0.86-1.09],0.636106291260201,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,5,1.05 [0.85-1.3],0.636796179339125,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,5,0.96 [0.81-1.14],0.637221140776396,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,AFP,Alpha-fetoprotein,Inverse variance weighted,5,1.05 [0.85-1.3],0.642759461881564,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,KIT,Mast/stem cell growth factor receptor Kit,Inverse variance weighted,5,1.03 [0.91-1.17],0.649490990218295,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,5,1.03 [0.91-1.16],0.652790197615654,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,5,1.05 [0.85-1.3],0.653078814330047,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,5,1.03 [0.91-1.16],0.655194181190028,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,5,1.04 [0.86-1.27],0.657087804539738,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,5,0.98 [0.87-1.09],0.660254384318368,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,BRK1,Protein BRICK1,Inverse variance weighted,5,0.96 [0.81-1.15],0.663445107237885,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CDH3,Cadherin-3,Inverse variance weighted,5,0.97 [0.83-1.12],0.666453283731376,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,5,1.03 [0.9-1.17],0.668041931620084,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TTR,Transthyretin,Inverse variance weighted,5,1.05 [0.85-1.29],0.668130752880694,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LGALS4,Galectin-4,Inverse variance weighted,5,1.03 [0.91-1.16],0.668574619350258,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,5,1.04 [0.86-1.27],0.672122500678942,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,1.03 [0.9-1.17],0.672895245517138,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,5,0.96 [0.81-1.15],0.674593538177191,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PI3,Elafin,Inverse variance weighted,5,1.03 [0.91-1.16],0.676113212384034,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,OMG,Oligodendrocyte-myelin glycoprotein,Inverse variance weighted,5,0.97 [0.85-1.11],0.682680242787408,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,5,1.03 [0.88-1.21],0.68326001458794,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,5,1.04 [0.86-1.26],0.685478419438791,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IMMT,MICOS complex subunit MIC60,Inverse variance weighted,5,0.97 [0.81-1.15],0.687515331842137,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CDH1,Cadherin-1,Inverse variance weighted,5,1.03 [0.9-1.17],0.690075578406713,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ANGPTL2,Angiopoietin-related protein 2,Inverse variance weighted,5,0.97 [0.84-1.12],0.691027406948062,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,5,0.97 [0.85-1.11],0.693343001787617,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SLAMF8,SLAM family member 8,Inverse variance weighted,5,1.03 [0.9-1.16],0.693424005898891,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ALCAM,CD166 antigen,Inverse variance weighted,5,0.96 [0.76-1.2],0.695113988815154,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MMP8,Neutrophil collagenase,Inverse variance weighted,5,1.03 [0.9-1.16],0.697135930251212,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,5,0.97 [0.84-1.13],0.697496799569215,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,5,1.03 [0.9-1.17],0.697914000651356,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,THBS2,Thrombospondin-2,Inverse variance weighted,5,0.98 [0.86-1.11],0.698932051601604,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,5,0.97 [0.85-1.11],0.7009071048388,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,5,1.04 [0.86-1.25],0.705804205777633,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CNDP1,Beta-Ala-His dipeptidase,Inverse variance weighted,5,1.03 [0.9-1.18],0.7062776530493,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IFNL1,Interferon lambda-1,Inverse variance weighted,5,1.03 [0.89-1.19],0.706299706338855,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CSTB,Cystatin-B,Inverse variance weighted,5,0.98 [0.87-1.1],0.706727934800478,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ANXA5,Annexin A5,Inverse variance weighted,5,1.04 [0.84-1.29],0.706743709698584,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,5,1.03 [0.87-1.22],0.710904737836045,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,5,1.04 [0.86-1.24],0.711700891166758,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD46,Membrane cofactor protein,Inverse variance weighted,5,0.97 [0.85-1.12],0.716828169498445,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,5,0.98 [0.88-1.09],0.719024656094477,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GRN,Progranulin,Inverse variance weighted,5,1.02 [0.9-1.16],0.721883834171431,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,5,0.98 [0.86-1.11],0.723131274785684,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,5,1.02 [0.9-1.17],0.723892176249924,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,5,0.98 [0.88-1.09],0.725016987091818,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,5,1.02 [0.92-1.13],0.729672382068667,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TCN2,Transcobalamin-2,Inverse variance weighted,5,1.02 [0.9-1.16],0.730100295662349,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,5,1.02 [0.9-1.16],0.731137508599891,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MPO,Myeloperoxidase,Inverse variance weighted,5,1.02 [0.9-1.17],0.732232134665249,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,5,0.98 [0.86-1.11],0.733785935194175,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,5,1.02 [0.91-1.14],0.739879297130604,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MDK,Midkine,Inverse variance weighted,5,0.98 [0.86-1.12],0.740893201492318,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,5,1.03 [0.88-1.19],0.743725549666632,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,5,0.98 [0.86-1.11],0.744311655583557,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NRP2,Neuropilin-2,Inverse variance weighted,5,0.98 [0.84-1.13],0.744856080764867,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,5,1.02 [0.9-1.17],0.745929139108962,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,5,0.98 [0.87-1.11],0.746735762513774,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,5,0.98 [0.85-1.13],0.746931365291352,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,EFNA1,Ephrin-A1,Inverse variance weighted,5,0.98 [0.86-1.12],0.74747640621396,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,5,0.97 [0.82-1.15],0.74937499922812,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NPPC,C-type natriuretic peptide,Inverse variance weighted,5,0.98 [0.87-1.1],0.749413264093816,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CTSV,Cathepsin L2,Inverse variance weighted,5,1.02 [0.9-1.16],0.750803605779431,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,5,0.97 [0.82-1.16],0.75097843255211,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,5,0.98 [0.87-1.11],0.752964622678139,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD7,T-cell antigen CD7,Inverse variance weighted,5,1.02 [0.9-1.16],0.756934160697562,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCL7,C-C motif chemokine 7,Inverse variance weighted,5,1.03 [0.86-1.23],0.757707990618597,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Inverse variance weighted,5,0.98 [0.86-1.12],0.758340711333832,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,5,1.02 [0.9-1.16],0.760212680837618,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RETN,Resistin,Inverse variance weighted,5,1.03 [0.87-1.21],0.761958392701361,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,5,0.98 [0.83-1.15],0.763705012701532,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CHGA,Chromogranin-A,Inverse variance weighted,5,0.98 [0.83-1.15],0.764160156938692,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LEP,Leptin,Inverse variance weighted,5,0.98 [0.88-1.1],0.765060353106636,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,5,0.98 [0.87-1.11],0.765669982890221,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,5,1.03 [0.87-1.21],0.7680317919494,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,5,1.02 [0.89-1.17],0.770357922979419,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,5,0.97 [0.82-1.16],0.771711651056511,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,5,0.98 [0.83-1.15],0.773416605676713,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,5,0.98 [0.88-1.1],0.779527683609799,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,5,0.98 [0.86-1.12],0.77993111761634,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,5,0.97 [0.81-1.17],0.780337537266479,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,5,0.99 [0.89-1.09],0.784101028116433,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RSPO1,R-spondin-1,Inverse variance weighted,5,0.98 [0.86-1.12],0.784358640293197,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,5,1.03 [0.85-1.23],0.787824919338407,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Inverse variance weighted,5,1.02 [0.9-1.16],0.789518619878297,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,5,1.02 [0.89-1.16],0.790501499653315,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,5,0.98 [0.87-1.11],0.790538436389854,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SPON2,Spondin-2,Inverse variance weighted,5,0.97 [0.79-1.2],0.790585042479791,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HNMT,Histamine N-methyltransferase,Inverse variance weighted,5,0.98 [0.83-1.15],0.790872381205686,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TGFA,Protransforming growth factor alpha,Inverse variance weighted,5,0.98 [0.86-1.12],0.791598986885393,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,5,0.98 [0.82-1.17],0.792345376215124,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PGA4,Pepsin A-4,Inverse variance weighted,5,0.98 [0.85-1.13],0.792463061452142,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCN5,CCN family member 5,Inverse variance weighted,5,0.98 [0.82-1.16],0.797993334664971,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TMSB10,Thymosin beta-10,Inverse variance weighted,5,1.02 [0.86-1.22],0.80113532283034,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SERPINA11,Serpin A11,Inverse variance weighted,5,0.99 [0.89-1.1],0.804557112730178,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RNASE4,Ribonuclease 4,Inverse variance weighted,5,0.98 [0.83-1.16],0.807124289984115,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FAM3C,Protein FAM3C,Inverse variance weighted,5,0.98 [0.86-1.12],0.808869257903857,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,5,1.02 [0.89-1.15],0.808945465073832,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,Inverse variance weighted,5,0.98 [0.82-1.17],0.810197670405638,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,5,0.98 [0.86-1.13],0.813080620683384,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,5,1.01 [0.9-1.15],0.814768787462297,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,5,0.98 [0.87-1.12],0.815625261177104,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,5,1.02 [0.87-1.19],0.815900100923566,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,5,0.99 [0.88-1.11],0.816342940004586,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,5,0.98 [0.86-1.12],0.818673771804641,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,XCL1,Lymphotactin,Inverse variance weighted,5,0.99 [0.88-1.11],0.819146451858889,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,5,0.98 [0.85-1.13],0.821916796369468,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCL14,C-C motif chemokine 14,Inverse variance weighted,5,1.01 [0.89-1.15],0.825292736242978,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,REG1A,Lithostathine-1-alpha,Inverse variance weighted,5,0.98 [0.82-1.17],0.828542524813539,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RNASET2,Ribonuclease T2,Inverse variance weighted,5,0.99 [0.87-1.12],0.83202314537717,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,5,1.02 [0.88-1.17],0.832507547663703,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,5,1.02 [0.86-1.2],0.832545044304802,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PTK7,Inactive tyrosine-protein kinase 7,Inverse variance weighted,5,0.99 [0.86-1.13],0.832626282571711,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SERPINA3,Alpha-1-antichymotrypsin,Inverse variance weighted,5,1.02 [0.87-1.2],0.834216528352166,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RAB6A,Ras-related protein Rab-6A,Inverse variance weighted,5,0.99 [0.87-1.12],0.835093247441969,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,5,0.99 [0.87-1.12],0.83601572617822,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCL19,C-C motif chemokine 19,Inverse variance weighted,5,1.01 [0.89-1.16],0.837711490819359,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FGFBP2,Fibroblast growth factor-binding protein 2,Inverse variance weighted,5,1.01 [0.88-1.16],0.841009744174177,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,Inverse variance weighted,5,0.99 [0.9-1.09],0.841738464772153,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,5,1.01 [0.88-1.17],0.844262943747096,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,5,1.02 [0.82-1.28],0.845556047693596,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,5,1.01 [0.89-1.15],0.851843583769444,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MMP7,Matrilysin,Inverse variance weighted,5,0.98 [0.81-1.2],0.853601486660867,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ORM1,Alpha-1-acid glycoprotein 1,Inverse variance weighted,5,0.98 [0.8-1.2],0.854079958802589,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,OCLN,Occludin,Inverse variance weighted,5,1.02 [0.82-1.28],0.854492527102284,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PVR,Poliovirus receptor,Inverse variance weighted,5,0.99 [0.89-1.1],0.85552928251261,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,5,1.01 [0.9-1.13],0.856471347175593,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,1.01 [0.87-1.18],0.85919222006729,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL19,Interleukin-19,Inverse variance weighted,5,0.99 [0.87-1.12],0.85938694089758,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,5,0.99 [0.88-1.11],0.86002783907876,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,EPO,Erythropoietin,Inverse variance weighted,5,1.01 [0.88-1.16],0.863511942840572,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,5,0.99 [0.87-1.12],0.864294813574678,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD302,CD302 antigen,Inverse variance weighted,5,1.01 [0.88-1.16],0.866976071892344,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,0.99 [0.87-1.13],0.870226237254813,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,5,1.01 [0.88-1.16],0.870790443547571,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Inverse variance weighted,5,0.99 [0.83-1.17],0.871662076617214,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,5,1.01 [0.86-1.2],0.872337809529361,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RBP7,Retinoid-binding protein 7,Inverse variance weighted,5,1.01 [0.89-1.15],0.874180278682956,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,5,0.99 [0.88-1.12],0.875663924047143,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ADGRE1,Adhesion G protein-coupled receptor E1,Inverse variance weighted,5,1.01 [0.89-1.15],0.875947873799489,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HGF,Hepatocyte growth factor,Inverse variance weighted,5,1.01 [0.89-1.15],0.876288487083225,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NFASC,Neurofascin,Inverse variance weighted,5,0.99 [0.88-1.12],0.876912872385234,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,5,1.01 [0.9-1.14],0.879272502831575,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ITGA11,Integrin alpha-11,Inverse variance weighted,5,0.98 [0.75-1.27],0.882079910591926,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,5,0.99 [0.88-1.12],0.882541883681953,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MMP10,Stromelysin-2,Inverse variance weighted,5,1.01 [0.89-1.15],0.883946123640945,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,5,0.99 [0.85-1.15],0.884155999483827,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,0.99 [0.84-1.16],0.886222318546652,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LGALS1,Galectin-1,Inverse variance weighted,5,1.02 [0.83-1.25],0.886866737282576,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LGALS9,Galectin-9,Inverse variance weighted,5,1.02 [0.83-1.25],0.887100591592455,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,5,0.99 [0.88-1.12],0.887186685970948,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,5,0.99 [0.87-1.13],0.888189166955983,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCL23,C-C motif chemokine 23,Inverse variance weighted,5,0.99 [0.87-1.12],0.88864735092472,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TREML2,Trem-like transcript 2 protein,Inverse variance weighted,5,0.99 [0.84-1.17],0.890181937330207,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,EGFR,Epidermal growth factor receptor,Inverse variance weighted,5,0.99 [0.87-1.13],0.893687809108779,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,5,1.01 [0.89-1.15],0.897312475234808,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,5,0.99 [0.88-1.12],0.900481339435904,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,BCAN,Brevican core protein,Inverse variance weighted,5,0.99 [0.83-1.18],0.901623341803982,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CA3,Carbonic anhydrase 3,Inverse variance weighted,5,1.01 [0.83-1.24],0.903386661890105,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,5,0.99 [0.88-1.12],0.903483829339975,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,5,1.01 [0.88-1.15],0.9044600798217,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,5,0.99 [0.87-1.13],0.904693521905932,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FOLR1,Folate receptor alpha,Inverse variance weighted,5,0.99 [0.86-1.14],0.906702929037945,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MATN2,Matrilin-2,Inverse variance weighted,5,1.01 [0.88-1.15],0.909961672923362,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MFAP5,Microfibrillar-associated protein 5,Inverse variance weighted,5,1.01 [0.89-1.15],0.910104880809349,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NPPB,Natriuretic peptides B,Inverse variance weighted,5,1.01 [0.88-1.15],0.912666741296096,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,5,1.01 [0.9-1.12],0.912939921523851,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CA6,Carbonic anhydrase 6,Inverse variance weighted,5,1.01 [0.87-1.16],0.915012732649395,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,5,0.99 [0.87-1.13],0.916412234068946,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,0.99 [0.87-1.13],0.917094538649665,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,BAMBI,BMP and activin membrane-bound inhibitor homolog,Inverse variance weighted,5,1.01 [0.88-1.15],0.921647765400623,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD70,CD70 antigen,Inverse variance weighted,5,1 [0.91-1.11],0.922089546584446,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,5,1.01 [0.88-1.14],0.928915342724175,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PAEP,Glycodelin,Inverse variance weighted,5,1 [0.9-1.1],0.93151525911229,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,5,0.99 [0.87-1.13],0.931943428719461,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CRTAC1,Cartilage acidic protein 1,Inverse variance weighted,5,0.99 [0.83-1.18],0.93720400645244,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,DLL1,Delta-like protein 1,Inverse variance weighted,5,1.01 [0.88-1.15],0.938863380300373,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,5,1.01 [0.86-1.17],0.940534501609101,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CX3CL1,Fractalkine,Inverse variance weighted,5,0.99 [0.8-1.23],0.941392972126837,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,5,0.99 [0.86-1.15],0.943267074626364,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,5,0.99 [0.83-1.2],0.943291673689954,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,5,1 [0.91-1.1],0.948391312799186,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCL20,C-C motif chemokine 20,Inverse variance weighted,5,1 [0.87-1.16],0.948854232251504,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RBP5,Retinol-binding protein 5,Inverse variance weighted,5,1 [0.88-1.15],0.950053894264337,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,5,1 [0.87-1.13],0.950236202850053,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,5,1 [0.9-1.1],0.95032321202408,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,5,1 [0.89-1.13],0.953265467130397,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SIGLEC1,Sialoadhesin,Inverse variance weighted,5,1 [0.88-1.13],0.955144679542173,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,5,1 [0.88-1.14],0.956925976148377,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,5,1 [0.89-1.13],0.957866729629525,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,THBD,Thrombomodulin,Inverse variance weighted,5,1 [0.87-1.16],0.958623504496993,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD48,CD48 antigen,Inverse variance weighted,5,1 [0.83-1.19],0.958650309900335,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,5,1 [0.84-1.18],0.959591049051373,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCL15,C-C motif chemokine 15,Inverse variance weighted,5,1 [0.89-1.11],0.961522334705466,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,5,1 [0.85-1.19],0.961735622912146,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,EFNA4,Ephrin-A4,Inverse variance weighted,5,1 [0.85-1.19],0.963969599070568,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SPON1,Spondin-1,Inverse variance weighted,5,1 [0.88-1.13],0.968302863446741,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PSG1,Pregnancy-specific beta-1-glycoprotein 1,Inverse variance weighted,5,1 [0.88-1.13],0.968630888410396,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD59,CD59 glycoprotein,Inverse variance weighted,5,1 [0.88-1.13],0.969456619955263,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CPM,Carboxypeptidase M,Inverse variance weighted,5,1 [0.88-1.14],0.980054386472875,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,5,1 [0.88-1.13],0.980478600219438,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,5,1 [0.87-1.15],0.980836421492087,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,5,1 [0.82-1.21],0.981745220613656,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,JAM2,Junctional adhesion molecule B,Inverse variance weighted,5,1 [0.83-1.21],0.982056706236951,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,5,1 [0.88-1.14],0.98273748319996,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,5,1 [0.88-1.13],0.983316457310245,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GM2A,Ganglioside GM2 activator,Inverse variance weighted,5,1 [0.89-1.12],0.984508215116894,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL22,Interleukin-22,Inverse variance weighted,5,1 [0.88-1.14],0.986166562226992,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,XPNPEP2,Xaa-Pro aminopeptidase 2,Inverse variance weighted,5,1 [0.86-1.17],0.986449843453529,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,5,1 [0.88-1.13],0.989211205946608,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,C1RL,Complement C1r subcomponent-like protein,Inverse variance weighted,5,1 [0.86-1.17],0.99198265443303,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,5,1 [0.88-1.14],0.992488027596269,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,1 [0.86-1.16],0.99576920902048,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NUCB2,Nucleobindin-2,Inverse variance weighted,5,1 [0.88-1.14],0.996757204914967,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SDC4,Syndecan-4,Inverse variance weighted,5,1 [0.88-1.14],0.999264388575472,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,5,1 [0.84-1.19],0.999703060918621,trans
